MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Deep brain stimulation lead position impact on parkinsonian non-motor symptoms

    J. Bardoň, S. Kurčová, M. Chudáčková, P. Otruba, D. Krahulík, M. Nevrlý, P. Kaňovský, J. Zapletalová, J. Valošek, P. Hluštík (Olomouc, Czech Republic)

    Objective: This study evaluated the direct impact of localization of deep brain stimulation electrodes active contact within the different parts of subthalamic nucleus on improvement…
  • MDS Virtual Congress 2020

    Correlation between location of active contacts and weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease

    K. Eguchi, I. Yabe, S. Shirai, M. Matsushima, T. Kano, K. Yamazaki, S. Hamauchi, T. Sasamori, K. Hirata, T. Seki, M. Kitagawa, M. Otsuki, T. Shiga, K. Hokin, H. Sasaki (Sapporo, Japan)

    Objective: Objective: The aim of this study was to evaluate the correlation between the location of active contacts and weight gain after subthalamic nucleus deep…
  • MDS Virtual Congress 2020

    Characterization of the pattern of daily motor fluctuations in Parkinson’s disease patients based on home diaries

    R. Hauser, W. Poewe, J. Ferreira, A. Lees, G. Liang, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (Tampa, FL, USA)

    Objective: Home diary-based representation of patients’ daily motor status. Background: Parkinson’s disease (PD) patients are often in their best clinical state when attending medical appointments.…
  • MDS Virtual Congress 2020

    Effect of opicapone and entacapone on daily pattern of motor fluctuations in Parkinson’s disease patients

    A. Lees, O. Rascol, J. Ferreira, O. Klepitskaya, M. Fonseca, D. Magalhães, J.F Rocha, P. Soares-da-Silva (London, United Kingdom)

    Objective: To evaluate the effect of opicapone (OPC) 50 mg versus entacapone (ENT) on daily pattern of motor fluctuations. Background: OPC, a once-daily catechol-O-methyltransferase inhibitor,…
  • MDS Virtual Congress 2020

    Apomorphine subcutaneous infusion reduces dopaminergic dosage whilst maintaining motor benefits in Parkinson’s disease: A prospective analysis of Thai Apomorphine Registry

    O. Phokaewvarangkul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate a reduction of LED in PD patients who achieve satisfactory motor control with long-term continuous subcutaneous apomorphine infusion (CSAI) Background: Apomorphine is…
  • MDS Virtual Congress 2020

    Targeting the Receptor of Glial Cell Line-Derived Neurotrophic factor to treat Parkinson’s Disease

    Y. Sidorova, A. Mahato, M. Saarma (Helsinki, Finland)

    Objective: Our goal is to develop small molecules which support and restore nigrostriatal dopamine neurons by activation of glial cell line-derived-neurotrophic factor (GDNF) receptors. Background:…
  • MDS Virtual Congress 2020

    Secondary Vascular Parkinsonism: Role of increasing levels cortisol in the cognitive impairment

    D. Akramova (Tashkent, Uzbekistan)

    Objective: Elevated cortisol levels are found in many diseases, including infectious, related to aging, depression, and associated with a depressive status. Elevated cortisol levels are…
  • MDS Virtual Congress 2020

    Atypical Psychogenic Nonepileptic Seizure (PNES) preceding Multiple System Atrophy (MSA)

    A. Shahinian, T. Mehta, A. Betcher, P. Janda, J. Mahajan, A. Vickers (Las Vegas, NV, USA)

    Objective: To share a case report of Atypical PNES and MSA. Background: Multiple system atrophy (MSA) is a rare neurodegenerative diagnosis that clinically presents with…
  • MDS Virtual Congress 2020

    MRI evaluation of Progressive Supranuclear Palsy

    M. Kamada (Kagawa, Japan)

    Objective: We aimed to evaluate the magnetic resonance imaging-derived parameters in differentiation of patients with progressive supranuclear palsy from patients with Parkinson’s disease and other…
  • MDS Virtual Congress 2020

    Use of Figurative Language in Describing OFF Periods in Parkinson’s Disease

    B. Edison, S. Mantri, M. Daeschler, C. Kopil, C. Marras, S. Kahl, L. Chahine (Pittsburgh, PA, USA)

    Objective: To explore the use of figurative language by individuals with Parkinson’s disease (PD) describing their experience during OFF periods. Background: OFF periods are characterized…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley